TF and cholangiocarcinoma: Based on a trial-and-error method following in-depth literature research, the culture medium was optimized (by adding a Rho-associated protein kinase (ROCK) inhibitor, forskolin, insulin, transferrin, and selenite), leading to the generation of stable CC organoid cultures that could be maintained long-term.